(Total Views: 760)
Posted On: 08/02/2017 11:00:54 AM
Post# of 9145
Nanologix Incorporated
NanoLogix N-Assay Bacteria Diagnostic Technology To Be Presented Today at AACC Annual Meeting in San Diego
The N-Assay Diagnostic is a novel Immunoassay for Simultaneous Identification and Determination of Antibiotic Susceptibility of Deinococcus Bacteria. The following information is being presented today at the American Association for Clinical Chemistry (AACC) 69th Annual Meeting in San Diego:
The significance of the results shown in the presentation cannot be understated, as with the addition of the Deinococcus results listed, the N-Assay now has demonstrated its applicability across a broad spectrum of bacteria which to date include E.coli, Group B Streptococcus, Enterococcus, and Gonorrhea, in addition to the yeast Candida.
You may follow this link to the AACC information website:
https://www.aacc.org/meetings-and-events/2017-annual-meeting
NanoLogix Incorporated
Local: 330-534-0800
Email: info@nanologix.com // Website: http://www.nanologix.com
NanoLogix N-Assay Bacteria Diagnostic Technology To Be Presented Today at AACC Annual Meeting in San Diego
The N-Assay Diagnostic is a novel Immunoassay for Simultaneous Identification and Determination of Antibiotic Susceptibility of Deinococcus Bacteria. The following information is being presented today at the American Association for Clinical Chemistry (AACC) 69th Annual Meeting in San Diego:
The significance of the results shown in the presentation cannot be understated, as with the addition of the Deinococcus results listed, the N-Assay now has demonstrated its applicability across a broad spectrum of bacteria which to date include E.coli, Group B Streptococcus, Enterococcus, and Gonorrhea, in addition to the yeast Candida.
You may follow this link to the AACC information website:
https://www.aacc.org/meetings-and-events/2017-annual-meeting
NanoLogix Incorporated
Local: 330-534-0800
Email: info@nanologix.com // Website: http://www.nanologix.com
(1)
(0)
